Status:
UNKNOWN
Creatine on Bone Mass in Postmenopausal Women
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
AlzChem AG
Conditions:
Postmenopausal Women
Eligibility:
FEMALE
50-80 years
Phase:
NA
Brief Summary
Animal, in vitro and small-scale studies have suggested that creatine supplementation may augment bone mass. This clinical trial aims to investigate the effects of a 2-year creatine supplementation pr...
Eligibility Criteria
Inclusion
- healthy postmenopausal women
- T-score at lumbar spine, or femoral neck or total femur of between -1SD and -2.5SD
Exclusion
- drugs or dietary supplements that may affect bone metabolism (e.g., bisphosphonates, AINEs, hormone replacement therapy, calcium, vitamin D, creatine supplementation)
- low BMI (\< 18.5 Kg/m2).
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01472393
Start Date
November 1 2011
End Date
December 1 2017
Last Update
January 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo - School of Medicine
São Paulo, São Paulo, Brazil, 01246-903